Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Duncan

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Tuberculosis (Edinburgh, Scotland)|May 22, 2003
Progress in TB drug development and what is still neededKen Duncan
Current Opinion in Microbiology|September 29, 2004
Prospects for new antitubercular drugsKen Duncan, Clifton E Barry
Current Molecular Medicine|May 17, 2007
Current strategies for identifying and validating targets for new treatment-shortening drugs for TBKerstin J Williams, Ken Duncan
Tuberculosis (Edinburgh, Scotland)|April 27, 2005
HemZ is essential for heme biosynthesis in Mycobacterium tuberculosisTanya Parish, Merrill Schaeffer, Gretta Roberts, et al.
The Lancet. Global Health|November 14, 2024
Access to antibiotics for pneumonia and sepsis in LMICsAmy Sarah Ginsburg, Ken Duncan, Keith P Klugman, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
New small-molecule synthetic antimycobacterialsLluis Ballell, Robert A Field, Ken Duncan, et al.
The Journal of Clinical Investigation|April 3, 2008
Confronting the scientific obstacles to global control of tuberculosisDouglas B Young, Mark D Perkins, Ken Duncan, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 2, 2007
Systems biology and its impact on anti-infective drug developmentMichael P Stumpf, Brian D Robertson, Ken Duncan, et al.
Journal of Bacteriology|March 6, 2007
Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabGTanya Parish, Gretta Roberts, Francoise Laval, et al.
Drug Discovery Today|May 2, 2026
Building and managing a complex drug discovery consortium: Insights from the tuberculosis drug acceleratorKelsey L Briggs, Betsy J Russell, Peter Warner, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Tuberculosis (Edinburgh, Scotland)|May 22, 2003
Progress in TB drug development and what is still neededKen Duncan
Current Opinion in Microbiology|September 29, 2004
Prospects for new antitubercular drugsKen Duncan, Clifton E Barry
Current Molecular Medicine|May 17, 2007
Current strategies for identifying and validating targets for new treatment-shortening drugs for TBKerstin J Williams, Ken Duncan
Tuberculosis (Edinburgh, Scotland)|April 27, 2005
HemZ is essential for heme biosynthesis in Mycobacterium tuberculosisTanya Parish, Merrill Schaeffer, Gretta Roberts, et al.
The Lancet. Global Health|November 14, 2024
Access to antibiotics for pneumonia and sepsis in LMICsAmy Sarah Ginsburg, Ken Duncan, Keith P Klugman, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
New small-molecule synthetic antimycobacterialsLluis Ballell, Robert A Field, Ken Duncan, et al.
The Journal of Clinical Investigation|April 3, 2008
Confronting the scientific obstacles to global control of tuberculosisDouglas B Young, Mark D Perkins, Ken Duncan, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 2, 2007
Systems biology and its impact on anti-infective drug developmentMichael P Stumpf, Brian D Robertson, Ken Duncan, et al.
Journal of Bacteriology|March 6, 2007
Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabGTanya Parish, Gretta Roberts, Francoise Laval, et al.
Drug Discovery Today|May 2, 2026
Building and managing a complex drug discovery consortium: Insights from the tuberculosis drug acceleratorKelsey L Briggs, Betsy J Russell, Peter Warner, et al.
Pageof 3